Tandem Diabetes Care

Youtube Subscribe

Open: 24.64 Close: 24.66 Change: 0.02

5 risks of investing in Tandem Diabetes Care found by an AI after reading the whole internet.

Are looking for the most relevant information about Tandem Diabetes Care? Investor spend a lot of time searching for information to make investment decisions in Tandem Diabetes Care. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Tandem Diabetes Care are: Tandem, Care, Diabetes, diabetes, Device, development, GlobalDatas, and the most common words in the summary are: diabetes, market, management, digital, care, device, tandem, . One of the sentences in the summary was: currently valued at $1.59 billion in market capitalization, …

Concept Map

Semantic Network

Stock Summary

Tandem Diabetes Care, Inc. designs, develops, and commercializes various products for people with insulin-dependent diabetes. The company's flagship product is the t:slim X2 insulin delivery system. It also provides t:S.

Today's Summary

Tandem Diabetes Care, Inc. currently valued at $1.59 billion in market capitalization, has a price-to-earnings ratio of -7.74 and a beta of 0.93. CFO Leigh Vosseller made a significant purchase of Tandem diabetes Care stock.

Today's News

GlobalDatas report Tandem Diabetes Care Medical Device Development provides an overview of the companys pipeline landscape and offers detailed analysis of its products in development. The main research and development focus of Tandem diabetes Care is on nutritional and metabolic diseases. Diabetes Treatment Device Market to Witness Huge Growth by 2030 – Roche, Tandem Diabetes Care, B. Braun Melsungen AG. Tandem diabetes Care creates new possibilities for people living with diabetes. Tandem Diabetes Care, Inc. currently valued at $1.59 billion in market capitalization, has a price-to-earnings ratio of -7.74 and a beta of 0.93. CFO Leigh Vosseller made a significant purchase of Tandem diabetes Care stock.

Stock Profile

"Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California."

Keywords

This document will help you to evaluate Tandem Diabetes Care without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Tandem Diabetes Care are: Tandem, Care, Diabetes, diabetes, Device, development, GlobalDatas, and the most common words in the summary are: diabetes, market, management, digital, care, device, tandem, . One of the sentences in the summary was: currently valued at $1.59 billion in market capitalization, has a price-to-earnings ratio of -7.74 and a beta of 0.93. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #diabetes #market #management #digital #care #device #tandem.

Read more →

Youtube Subscribe

---